IQVIA Scribe vs TrialPACE
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
IQVIA Scribe
This application allows patients participating in clinical trials to securely capture and submit data directly from their mobile devices. It provides relevant questionnaires throughout the study duration, amplifying patient voices in research.
- Online/offline data capture
- Patient enrollment notifications
- Study-specific questionnaires
- Secure data submission
- Automated eCOA process
Read full descriptionHide full description
IQVIA Scribe is an online/offline application used to capture data directly from patients enrolled in clinical trials. Patients enrolled in a study using Scribe will receive an enrollment notification via email or text with a link to download the application and instructions used to enroll in the study. Relevant questionnaires will be available for completion throughout the duration of the study ++++Scribe amplifies the patient's voice in clinical research by allowing Clinical Outcomes Assessments to be used in more trials. Whether deploying to smartphones, tablets or the web, our Sculptor visual build and deployment tools help automate the eCOA process, giving absolute transparency and greater control to sponsors and CRO’s.
TrialPACE
This application assists with clinical outcomes assessments for patients. It is designed for use within clinical trials to gather and manage patient data efficiently. The tool supports healthcare professionals in their research and patient monitoring efforts.
- Clinical outcomes assessments
- Patient data management
- Research support
- Patient monitoring
- Healthcare professional tool
Read full descriptionHide full description
Application for ClinTrak Clinical Outcomes Assessments
Screenshots
Verdict
The clearest difference is rating: TrialPACE at 4.0 against IQVIA Scribe's 3.0. TrialPACE also leads on review sentiment (50% vs 20%) and update cadence (every 2 weeks vs every 2 months). IQVIA Scribe's advantage is ratings volume (37 vs 7) and iOS requirement (15.5 vs 26.0). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
TrialPACE holds the better App Store score, 4.0 against 3.0. That said, the two scores are not equally well evidenced: IQVIA Scribe has 37 ratings behind it against 7, so its average is the more settled of the two. Written reviews point the same way: 20% of IQVIA Scribe's written reviews are positive against 50% of TrialPACE's.
IQVIA Scribe ships an update every 2 months, TrialPACE every 2 weeks. The most recent releases landed on October 15, 2026 and October 6, 2026 respectively.
| Parameter | IQVIA Scribe | TrialPACE |
|---|---|---|
| Price | Free | Free |
| Rating | 3.0 (37 ratings) | 4.0 (7 ratings) — better |
| Positive reviews | 20.0% of reviews | 50.0% of reviews — better |
| Number of ratings | 37 — better | 7 |
| Update frequency | Every 2 months | Every 2 weeks — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod — better | iPhone, iPad |
| Requires iOS | 15.5 — better | 26.0 |
| Further details — not scored | ||
| Size | 33 MB | 25 MB |
| Age rating | 4+ | 4+ |
| Developer | IQVIA RDS INC. | Medpace |
Customer experience
IQVIA Scribe
TrialPACE
In-app purchases
IQVIA Scribe
No in-app purchases
TrialPACE
No in-app purchases
